Differentiated Thyroid Cancer (DTC)

9 clinical trials · Condition

Record	Firm	Date
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer (NCT04940052)	Novartis Pharmaceuticals	2021-11-15
Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening (NCT07229859)	Ruijin Hospital	2018-01-01
A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China (NCT02966093)	Eisai Co., Ltd.	2017-01-11
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma (NCT02432274)	Eisai Limited	2014-12-29
Nintedanib(BIBF1120) in Thyroid Cancer (NCT01788982)	European Organisation for Research and Treatment of Cancer - EORTC	2014-05-01
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting (NCT02041260)	Thomas Jefferson University	2014-01-01

Every clearance here is in the API, with alerts when new ones post.